{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:14:59Z","timestamp":1792613699845,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003356","name":"Gazi University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003356","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Using intraoperative MRI (iMRI) in glioma surgery can enhance the extent of resection (EOR) and improve survival rates for patients diagnosed with low grade gliomas (LGG) or high grade gliomas (HGG). This study focused on patients who underwent iMRI-guided surgery for LGG and HGG at our center. Our objective was to compare the patient survival time and recurrence rate between supratotal resection (SpTR) and gross total resection(GTR). To the best of our knowledge, this is the first study comparing SpTR with GTR using iMRI in glioma surgery. This study included 71 patients who had undergone iMRI-guided GTR and SpTR. The volume of the tumors was measured using postcontrast 3D T1W series and 3D FLAIR series taken the day before surgery, and the volume of the operation cavity was calculated from iMRI images. The effects of SpTR and GTR on overall and progression-free survival (OS and PFS) were analyzed by the log-rank test using Kaplan\u2012Meier curves. The associations between the extent of resection and tumor grade, and between recurrence and tumor grade were examined using the chi-square test. The rate of recurrence in patients diagnosed with HGG was greater than that in patients diagnosed with LGG (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.022). While patients who received SpTR had a greater OS time (105.9 months) than did those who underwent GTR (92.8 months), the difference was not statistically significant. The patients with LGG had a significantly longer PFS time than did the patients with HGG (86.5\u2009\u00b1\u20095.9 months, 95% CI\u2009=\u200974.9\u201398.2,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.0001). Of 23 patients diagnosed with HGG, SpTR was achieved in 9 and GTR was achieved in 14. The median OS time was longer in patients who underwent SpTR than in those who underwent GTR, but there was no statistically significant difference [101.2\u2009\u00b1\u200920.5 months (95% CI: 80.7\u2013121.7) vs. 70.6\u2009\u00b1\u20099.9 (95% CI: 60.7\u201380.5)\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.9]. Neurosurgeons are increasingly choosing SpTR, especially in LGGs. Despite their slow growth, LGGs retain the potential for malignant transformation. This situation underscores the importance of maximum safe resection in the surgery of LGGs. iMRI-guided resection makes it easier for surgeons to show the EOR concurrent with the operation.\n                  <\/jats:p>","DOI":"10.1007\/s10143-025-03301-x","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T20:27:47Z","timestamp":1738787267000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pushing the boundaries of neurosurgical oncology: evaluating the superiority of supratotal resection over gross total resection in intraoperative MRI-guided glioma surgery"],"prefix":"10.1007","volume":"48","author":[{"given":"Leyla Salimli","family":"Mirzayeva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"U\u00e7ar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00fcmeyye Nur","family":"Budak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet Memduh","family":"Kaymaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nezih","family":"Yayl\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,6]]},"reference":[{"key":"3301_CR1","doi-asserted-by":"publisher","first-page":"14554","DOI":"10.1038\/s41598-021-93986-z","volume":"11","author":"S Hirono","year":"2021","unstructured":"Hirono S, Ozaki K, Kobayashi M et al (2021) Oncological and functional outcomes of supratotal resection of IDH1 wild-type glioblastoma based on 11\u00a0C-methionine PET: a retrospective, single-center study. Sci Rep 11:14554. https:\/\/doi.org\/10.1038\/s41598-021-93986-z","journal-title":"Sci Rep"},{"key":"3301_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-017-2559-9","author":"F Pessina","year":"2017","unstructured":"Pessina F, Navarria P, Cozzi L et al (2017) Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience. J Neurooncol. https:\/\/doi.org\/10.1007\/s11060-017-2559-9. 135:129\u2013\u200939","journal-title":"J Neurooncol"},{"key":"3301_CR3","doi-asserted-by":"publisher","unstructured":"Hervey-Jumper SL, Berger MS. Maximizing safe resection of low- and high-grade glioma. J Neurooncol.130:269\u2013\u200982., Motomura K, Ohka F, Aoki K et al (2016) (2022) Supratotal Resection of Gliomas With Awake Brain Mapping: Maximal Tumor Resection Preserving Motor, Language, and Neurocognitive Functions. Front Neurol.;13:874826. https:\/\/doi.org\/10.3389\/fneur.2022.874826","DOI":"10.3389\/fneur.2022.874826"},{"key":"3301_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.874826","author":"K Motomura","year":"2022","unstructured":"Motomura, K., Ohka, F., Aoki, K., & Saito, R. (2022). Supratotal Resection of Gliomas With Awake Brain Mapping: Maximal Tumor Resection Preserving Motor, Language, and Neurocognitive Functions. Frontiers in neurology, 13, 874826. https:\/\/doi.org\/10.3389\/fneur.2022.874826 https:\/\/doi.org\/10.3389\/fneur.2022.874826","journal-title":"Frontiers in neurology"},{"key":"3301_CR5","doi-asserted-by":"publisher","unstructured":"Bello L, Fava E, Carrabba G, Papagno C et al (2010) Present day\u2019s standards in microsurgery of low-grade gliomas. Adv Tech Stand Neurosurg 35. https:\/\/doi.org\/10.1007\/978-3-211-99481-8_5. 113\u2013\u200957","DOI":"10.1007\/978-3-211-99481-8_5"},{"key":"3301_CR6","doi-asserted-by":"publisher","DOI":"10.3171\/2019.2.JNS183408","author":"M Rossi","year":"2019","unstructured":"Rossi M, Ambrogi F, Gay L et al (2019) Is supratotal resection achievable in low-grade gliomas? Feasibility, putative factors, safety, and functional outcome. J Neurosurg. https:\/\/doi.org\/10.3171\/2019.2.JNS183408. 132:1692\u2013\u2009705","journal-title":"J Neurosurg"},{"key":"3301_CR7","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.3390\/cancers15092493","volume":"15","author":"D Kreatsoulas","year":"2023","unstructured":"Kreatsoulas D, Damante M, Gruber M et al (2023) Supratotal Surgical Resection for Low-Grade Glioma: a systematic review. Cancers (Basel) 15:2493. https:\/\/doi.org\/10.3390\/cancers15092493","journal-title":"Cancers (Basel)"},{"key":"3301_CR8","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3390\/jpm13030383","volume":"13","author":"SH Baik","year":"2023","unstructured":"Baik SH, Kim SY, Na YC et al (2023) Supratotal Resection of Glioblastoma: Better Survival Outcome than Gross Total Resection. J Pers Med 13:383. https:\/\/doi.org\/10.3390\/jpm13030383","journal-title":"J Pers Med"},{"key":"3301_CR9","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1016\/j.wneu.2023.07.020","volume":"179","author":"PA Aziz","year":"2023","unstructured":"Aziz PA, Memon SF, Hussain M et al (2023) Supratotal Resection: an emerging Concept of Glioblastoma Multiforme surgery-systematic review and Meta-analysis. World Neurosurg 179:e46\u2013e55. https:\/\/doi.org\/10.1016\/j.wneu.2023.07.020","journal-title":"World Neurosurg"},{"key":"3301_CR10","doi-asserted-by":"publisher","first-page":"25755","DOI":"10.18632\/oncotarget.8367","volume":"7","author":"IY Ey\u00fcpoglu","year":"2016","unstructured":"Ey\u00fcpoglu IY, Hore N, Merkel A et al (2016) Supra-complete surgery via dual intraoperative visualization approach (DiVA) prolongs patient survival in glioblastoma. Oncotarget 7:25755\u201325768. https:\/\/doi.org\/10.18632\/oncotarget.8367","journal-title":"Oncotarget"},{"key":"3301_CR11","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/neuonc\/noy166","volume":"1","author":"CN de Leeuw","year":"2019","unstructured":"de Leeuw CN, Vogelbaum MA (2019) Supratotal resection in glioma: a systematic review. Neuro Oncol 1:179\u2013188. https:\/\/doi.org\/10.1093\/neuonc\/noy166","journal-title":"Neuro Oncol"},{"key":"3301_CR12","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s41016-020-00198-x","volume":"6","author":"L Li","year":"2020","unstructured":"Li L, Wang Y, Li Y et al (2020) Role of molecular biomarkers in glioma resection: a systematic review. Chin Neurosurg J 6:18. https:\/\/doi.org\/10.1186\/s41016-020-00198-x","journal-title":"Chin Neurosurg J"},{"key":"3301_CR13","doi-asserted-by":"publisher","unstructured":"Karschnia P, Gerritsen JKW, Teske N et al (2024) The oncological role of resection in newly diagnosed diffuse adult-type glioma defined by the WHO 2021 classification: a Review by the RANO resect group. Lancet Oncol.e404-e419. https:\/\/doi.org\/10.1016\/S1470-2045(24)00130-X","DOI":"10.1016\/S1470-2045(24)00130-X"},{"key":"3301_CR14","doi-asserted-by":"publisher","unstructured":"Kawaguchi T, Sonoda Y, Shibahara I et al (2016) Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1\/2 mutation without the 1p\/19q co-deletion. J Neurooncol 505\u2013514. https:\/\/doi.org\/10.1007\/s11060-016-2201-2","DOI":"10.1007\/s11060-016-2201-2"},{"key":"3301_CR15","doi-asserted-by":"publisher","unstructured":"Koriyama S, Nitta M, Kobayashi T et al (2018) A surgical strategy for lower grade gliomas using intraoperative molecular diagnosis. Brain Tumor Pathol 159\u2013167. https:\/\/doi.org\/10.1007\/s10014-018-0324-1","DOI":"10.1007\/s10014-018-0324-1"},{"key":"3301_CR16","doi-asserted-by":"publisher","unstructured":"Beiko J, Suki D, Hess KR et al (2014) IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection. Neuro Oncol 81\u201391. https:\/\/doi.org\/10.1093\/neuonc\/not159","DOI":"10.1093\/neuonc\/not159"},{"key":"3301_CR17","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3988\/jcn.2018.14.3.393","volume":"14","author":"JH Phi","year":"2018","unstructured":"Phi JH, Lee SJ, Kang HS et al (2018) Postoperative transient neurologic dysfunction: a proposal for pathophysiology. J Clin Neurol 14:393\u2013400. https:\/\/doi.org\/10.3988\/jcn.2018.14.3.393","journal-title":"J Clin Neurol"},{"key":"3301_CR18","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3109\/02688697.2015.1133803","volume":"30","author":"Y Ibe","year":"2016","unstructured":"Ibe Y, Tosaka M, Horiguchi K et al (2016) Resection extent of the supplementary motor area and post-operative neurological deficits in glioma surgery. Br J Neurosurg 30:323\u2013329. https:\/\/doi.org\/10.3109\/02688697.2015.1133803","journal-title":"Br J Neurosurg"},{"key":"3301_CR19","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s11060-021-03731-9","volume":"152","author":"JK Tabor","year":"2021","unstructured":"Tabor JK, Bonda D, LeMonda BC et al (2021) Neuropsychological outcomes following supratotal resection for high-grade glioma: a review. J Neurooncol 152:429\u2013437. https:\/\/doi.org\/10.1007\/s11060-021-03731-9","journal-title":"J Neurooncol"},{"key":"3301_CR20","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s11060-024-04660-z","volume":"168","author":"L Mirzayeva","year":"2024","unstructured":"Mirzayeva L, Ucar M, Kaymaz AM et al (2024) Intraoperative magnetic resonance imaging in glioma surgery: a single-center experience. J Neurooncol 168:249\u2013257. https:\/\/doi.org\/10.1007\/s11060-024-04660-z","journal-title":"J Neurooncol"},{"key":"3301_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2017.3.JNS162383","volume":"129","author":"Y Fujii","year":"2018","unstructured":"Fujii Y, Muragaki Y, Maruyama T et al (2018) Threshold of the extent of resection for WHO Grade III gliomas: retrospective volumetric analysis of 122 cases using intraoperative MRI. J Neurosurg 129:1\u20139. https:\/\/doi.org\/10.3171\/2017.3.JNS162383","journal-title":"J Neurosurg"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-025-03301-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-025-03301-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-025-03301-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T04:18:39Z","timestamp":1772079519000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-025-03301-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,6]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3301"],"URL":"https:\/\/doi.org\/10.1007\/s10143-025-03301-x","relation":{},"ISSN":["1437-2320"],"issn-type":[{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,6]]},"assertion":[{"value":"9 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee approval for this study was obtained from the Clinical Research Ethics Committee of Gazi University Faculty of Medicine on February 7, 2022, with the protocol number 99.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"200"}}